1. Leapfrog Engineering Services acquisition - 6.37% for ₹19.92 cr Delivered - At the June 24, 2026 announcement, the Company completed acquisition of 90,30,000 Leapfrog Engineering Services Ltd shares at INR 22.06 each (including INR 21.06 premium), aggregating INR 19,92,01,800 in cash for a 6.37% shareholding, with no regulatory approvals required. The acquisition was completed on June 24, 2026 as stated.
2. Resolution Plan commitments - CIRP payments and equity restructuring Pending - At the March 26, 2025 announcement, the Resolution Plan committed payment of CIRP costs in full and in priority, 0.50% to Statutory Creditors and 1% to Operational Creditors (Others) with balances written off, workmen and employee dues in full, retention of existing equity up to Rs. 1,00,000 with the erstwhile promoters' balance written off, and payments through a Special Purpose Vehicle; the financial plan was later revised to ₹45,00,00,000 from ₹35,15,10,247, subject to members' approval. Our record holds no disclosure of CoC or NCLT approval, the Effective Date, or any payments made under the plan.
3. Joint Venture Agreement with Mr. Narendra Shelar Pending - At the Board meeting of February 10, 2023, the Board approved the Joint Venture Agreement with Mr. Narendra Shelar, alteration of the Memorandum of Association subject to shareholder approval via Postal Ballot, and appointment of Mr. Narendra Shrimali as CFO. Our record holds no disclosure of the JV's execution, the MoA alteration, or its operational status.
4. Preferential allotment - 16,05,000 shares at ₹36.10 each Partial - At the November 29, 2022 approval, the Company approved preferential allotment of 16,05,000 equity shares of face value Rs. 10/- each at Rs. 36.10/- each; after the share split, this became 1,60,50,000 shares of face value Rs. 1/- each at Rs. 3.61/- each, with ratification sought at a revised price. The allotment was not completed within 15 days of Shareholders/Stock Exchange approval, requiring ratification under Regulation 170(1), and our record holds no disclosure of final completion after the split.
5. Share split - 1 share of ₹10 into 10 shares of ₹1 Delivered - At the September 28, 2022 announcement, the Board recommended a split of 1 equity share of face value Rs. 10/- each into 10 equity shares of Re. 1/- each fully paid-up, subject to shareholder and other approvals. The sub-division was completed with record date January 20, 2023 and allotment of Rs. 1/- shares on January 21, 2023, following postal ballot approval on October 29, 2022.
6. Gold jewellery subsidiary - gradual transfer of gold jewellery business Pending - At the September 28, 2022 announcement, the Board approved formation of a new subsidiary for the gold jewellery business, with the gold jewellery business of Deep Diamond India Ltd to be transferred gradually into it through a business transfer agreement post incorporation. Our record holds no disclosure of the subsidiary's incorporation or any transfer; the Company reported a Jewellery Business segment through FY25 and the FY23 annual report describes two segments, 'diamond Jewellery' and 'Pharmaceuticals'.
7. MoA main object alteration - to pharmaceutical and healthcare industry Delivered - At the September 28, 2022 announcement, the Board proposed altering the main object of the MoA to the pharmaceutical and healthcare industry, to be approved by shareholders via postal ballot with e-voting from September 30, 2022 to October 29, 2022. The Company now operates two segments, 'diamond Jewellery' and 'Pharmaceuticals', and Pharmaceutical Business revenue grew from ₹1.50 cr in FY24 to ₹4.25 cr in FY26.
8. Borrowing limit increase - to ₹100 cr under Section 180(1)(a) Pending - At the Board meeting of August 28, 2023, the Board approved increasing the borrowing limit to INR 100 Crores under Section 180(1)(a) of the Companies Act, 2013, with creation of mortgage/charge on movable/immovable properties, recommended as a Special Resolution. Our record holds no disclosure of shareholder approval or of any borrowing under the increased limit; Debt stood at ₹0.37 cr with D/E of 0.01 as of August 31, 2026.
9. Deep Health India AI launch - one million scans in first year On track - At the November 13, 2025 announcement, the Company launched Deep Health India AI priced at ₹35 per single scan and ₹75 for a pack of three, with subscription plans and Deep Points loyalty credits, targeting one million scans in the first year. The product, web portal and data servers have undergone multi-phase readiness tests for over 150,000 concurrent users, and a CDSCO registration application was filed as a precautionary measure; no scan volumes are disclosed as of August 31, 2026.
10. Rights issue - up to ₹45 cr for Oasis Ceramics acquisition, GCP and issue expenses Missed - At the Board meeting of August 14, 2025, the Board approved raising up to ₹45 crores through a rights issue, primarily for the acquisition of Oasis Ceramics Private Limited under the IBC, 2016, general corporate purposes and issue expenses; the closing was extended from September 19 to September 24, 2025, and the Oasis Ceramics object was later marked "Nil (Object Discontinued)". The issue raised ₹39.98 crore with allotment approved October 06, 2025, but the Oasis Ceramics acquisition was discontinued and only Rs. 2.5 crore went to the stated objects, with Rs. 37.47 crore invested in securities through recognised stock exchanges - a deviation ratified by shareholders at the EGM on 22nd January 2026.